Go to Wolters Kluwer VitalLaw.comGo to Wolters Kluwer VitalLaw.com
VitalLaw®
  • Find answers to your questions
  • Log in to access your subscriptions
In depth. On point.
In depth. On point.
  • Home
  • Legal Directory
  • Home
  • Legal Directory
In depth. On point.
  • Articles
    • Articles
  • Law Firms
    • Law Firms
  • Organizations
    • Organizations
    • ELECTRONIC HEALTH RECORDS—7th Cir.: Court remands consolidated hospital privacy breach lawsuit back to state court
    • ADMINISTRATION OF MEDICARE/MEDICAID PROGRAMS—DAB DECISIONS: Inadvertent omission of ‘medical director’ information on revalidation application grounds for enrollment and billing revocation, 10-year re-enrollment bar
      • You have 1 more complimentary views available this month. Log in if you are already a customer
    • ADVERTISING (FOOD, DRUG & MEDICAL DEVICES)—N.D. Cal.: Henry Meds must collect ESI from cloud-based platforms
      • You have 1 more complimentary views available this month. Log in if you are already a customer
    • CIVIL MONEY PENALTIES—NOTICES: No Adjustment to HHS Civil Monetary Penalty Amounts for 2026
      • You have 1 more complimentary views available this month. Log in if you are already a customer
    • DRUGS AND BIOLOGICS—NOTICES: Electronic Common Technical Document (eCTD); Data Standards; Supporting Forward Compatibility for eCTD 4.0
      • You have 1 more complimentary views available this month. Log in if you are already a customer
    • END-STAGE RENAL DISEASE—OTHER AGENCY DOCUMENTS: HHS Kidney Care National Plan calls for competition, prevention, and transplant reform
      • You have 1 more complimentary views available this month. Log in if you are already a customer
    • EXPERT INSIGHTS—FinCEN Targets $17.5 Billion In Suspected Health Care Fraud
      • You have 1 more complimentary views available this month. Log in if you are already a customer
    • ORGAN PROCUREMENT AND TRANSPLANTATION—OTHER AGENCY DOCUMENTS: ASPE data brief shows health and economic benefits associated with increased kidney transplantation
      • You have 1 more complimentary views available this month. Log in if you are already a customer
    • PRESCRIPTION DRUGS—FDA GUIDANCE NOTICES: Regulatory Considerations for Prescription Drug Use-Related Software; Guidance for Industry; Availability
      • You have 1 more complimentary views available this month. Log in if you are already a customer
  • Articles
    • Articles
  • Law Firms
    • Law Firms
  • Organizations
    • Organizations

    Health Law Daily Wrap Up, PRESCRIPTION DRUGS—FDA GUIDANCE NOTICES: Regulatory Considerations for Prescription Drug Use-Related Software; Guidance for Industry; Availability, (Oct 22, 2026)

    By WK Editorial Staff

    The Food and Drug Administration (FDA or Agency) is announcing the availability of a final guidance for industry titled "Regulatory Considerations for Prescription Drug Use-Related Software."

    This final guidance describes FDA’s application of i ...

    © 2026 CCH Incorporated and its affiliates and licensors. All rights reserved.

    • Manage Cookie Preferences
    • Privacy Statement
    • Terms of Use